RxTran Awarded Second U.S. Patent for Technology That Lets Pharmacists Verify a Translation They Cannot Read

Patent ExpiryapprovedPositive

AI Analysis

Summary

Language Scientific's RxTran has been awarded a second U.S. patent for technology enabling pharmacists to verify prescription translations they cannot read, extending capabilities to hospital discharge and emergency instructions.

Outcome Details

Second U.S. patent granted for RxTran translation verification technology

Importance:3/10

Sentiment:

0.60

patentintellectual propertypharmaceutical technologytranslation verificationpharmacy

Read the original article

Published by PR Newswire Biotech on September 17, 2026 1:58 PM

Read Original